Why the study?
Does a single-lead ICD system with atrial-sensing electrodes reduce inappropriate ICD therapy compared to standard single-lead ICDs in patients undergoing primary prophylactic implantation?
Does a single-lead ICD system with atrial-sensing electrodes reduce inappropriate ICD therapy compared to standard single-lead ICDs in patients undergoing primary prophylactic implantation?
The use of a single-lead ICD with atrial-sensing electrodes significantly reduces the incidence of inappropriate therapies compared to standard single-lead ICDs, without increasing operative burden or complications.
Answers are grounded in this paper and cite their sources.
May reduce inappropriate therapies with single-chamber ICDs; leaves open need for randomized confirmation before practice change.
INTRODUCTION: The single-chamber implantable cardioverter-defibrillator (ICD) can be associated with more frequent inappropriate therapies compared with dual-chamber ICDs, when they are accompanied by a simpler implantation procedure. The aim of this study was to investigate whether the use of a single-lead ICD system with atrial-sensing electrodes results in a reduction of inappropriate ICD therapy. METHODS AND RESULTS: The study population consisted of 212 consecutive patients, who underwent primary prophylactic single-lead ICD implantation at our institute. A ventricular lead with atrial-sensing electrodes was implanted in 77 patients (36%; Group-VDD) and a ventricular lead without atrial-sensing electrodes was implanted in 135 patients (64%; Group-VVI). Procedural and follow-up data were collected in a prospective registry. A higher prevalence of atrial fibrillation was present in Group-VDD. There were no other significant differences in patient baseline characteristics (age, sex, and other comorbidities) or follow-up period between the two groups. The operative parameters including fluoroscopic burden showed no significant differences between Group-VDD and Group-VVI. During a mean follow-up period of 697 ± 392 days, 26 patients (12%) experienced appropriate ICD therapies and 13 patients (6%) suffered inappropriate ICD therapies. The incidence of inappropriate ICD therapies in Group-VDD was significantly lower as compared to that of Group-VVI (1/77 [1%] vs 12/135 [9%]; log-rank, P = 0.028). The incidence of appropriate ICD therapies and the occurrence of device-related complications showed no significant difference between the two groups. CONCLUSION: Single-lead ICD with atrial-sensing electrodes shows a lower incidence of inappropriate ICD therapy compared with the absence of atrial-sensing electrodes, without additional operative burden or increased complications.
No takes yet. Share an insight, caveat, or question.
Kurt et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: